Christopher Posner - PRESIDENT AND CEO, Director at Cara Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
PRESIDENT AND CEO, Director
Stock Symbol
CARA on Nasdaq
All Insider Reports
All Insider Reports

Christopher Posner - trading volume in the past year for Cara Therapeutics, Inc.

Holdings reported by Christopher Posner for Cara Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 169K $48.9K $0.29 Nov 4, 2024 Direct

Transactions reported by Christopher Posner for Cara Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.